Drug Shortage Report for ONDEXXYA
| Report ID | 257138 |
| Drug Identification Number | 02538539 |
| Brand name | ONDEXXYA |
| Common or Proper name | LEVOTHYROXINE |
| Company Name | ASTRAZENECA CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | ANDEXANET ALFA |
| Strength(s) | 200MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 90 BTL |
| ATC code | V03AB |
| ATC description | |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2022-11-20 |
| Estimated end date | 2025-12-31 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-08-06 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | Please contact AstraZeneca Canada Medical Information for any specific questions at 1-800-668-6000 (EN) or 1-800-461-3787 (FR) or by email: [email protected]. |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2025-08-06 | French | Compare |
| v3 | 2025-08-06 | English | Compare |
| v2 | 2025-08-06 | French | Compare |
| v1 | 2025-08-06 | English | Compare |
Showing 1 to 4 of 4